Tuesday, April 4, 2017

Novel drug delivery beats swine flu at gene level

Scientists found a new approach to deliver anti-viral RNAi to target cells against the H1N1 influenza virus. This new method proposed by scientists involves focus on training the human body to produce interferons faster. Scientists are suggesting to use hybrid spherical microcontainers that contain antiviral RNAs to activate the cell immune system. During their study, they used short interfering RNA with microcontainers to interact with the matrix RNA of the influenza virus and found that it lead to the degradation of the viral RNA. By doing this, the viral gene expression is reduced and enhancing the body's immunity against the influenza virus. After their first study by using this new method, tests showed that there was a drop of about 80% in the amount of virus proteins. It seems that scientists are getting closer and closer to the solutions to neutralize viruses like the H1N1 virus.

No comments:

Post a Comment